Hypophosphatemia

Clinical Features

• CNS
  • Weakness
  • Circumoral and fingertip paresthesias
  • Decreased DTRs
  • Decreased Mental Status
• Cardiac
  • Impaired myocardial function

Diagnosis

• 2.5-2.8 Mild
• 1.0-2.5 Mod
• <1.0 Severe

Treatment

• Mild-mod
  • KPhos /neutra phos PO
• Severe
  • KPhos 2.5-5 mg/kg IV over 6hr

Harbor UCLA Adult Treatment Guidelines

• Serum phosphate 1 mg/dl to 2 mg/dl
  • Able to take PO
    • Minimize or eliminate all dextrose-containing IV solutions
    • Aggressively treat acidosis
    • 1 tab K-phos neutral 250mg Q hour x 5 doses
      • Each tab contains phosphorus 8 mmol, Na 13 mEq, K1.1 mEq
    • Recheck serum phosphate after last dose, and repeat dosing if continues to be <2 mg/dl
  • NOT able to take PO
    • Minimize or eliminate all dextrose-containing IV solutions
    • Aggressively treat acidosis
    • Give 15 mmol of IV potassium phosphate over 2.5 hours (contains 22 mEq K)
      • Peripheral administration may cause burning at injection site
      • Consider central venous administration, if available
      • Repeat dosing regimen if serum phosphate remains <2 mg/dl
• Serum phosphate <1 mg/dl
  • Minimize or eliminate all dextrose-containing IV solutions
    • Exceptions: vasopressors, sedatives, analgesics, antibiotics, blood products, NS
  • Aggressively treat acidosis
  • Give 45 mmol of IV potassium phosphate over 7 hours (contains 66 mEq of K)
    • Peripheral administration may cause burning at injection site
    • Consider central venous administration, if available
  • If patient can tolerat PO, ALSO follow steps 1 above
  • Recheck serum phosphate after infusion
    • Repeat IV administration if <1 mg/dl
    • Consider oral administration if >1mg and <2 mg/dl

See Also

• Electrolyte Abnormalities (Main)